CIK 0001726445 · Non-accelerated filer<br>Smaller reporting company
Seer, Inc.
Sign in to watch- Ticker
- SEER
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821153150
- Phone
- 650-453-0000
- Business address
- 3800 BRIDGE PARKWAY, SUITE 102, REDWOOD CITY, CA, 94065
- Former names
- Seer Biosciences, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $14,809
- in 1 filing
Net −$14,809. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 40 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-18 | Farokhzad Omid CEO AND CHAIR | Sale | −24,385 | $1.99 | $49K | 3,349,064 |
| 2026-02-03 | Horn David R. PRESIDENT & CFO | Grant or award | +79,000 | 509,005 | ||
| 2026-02-03 | Horn David R. PRESIDENT & CFO | Grant or award · Employee Stock Option (right to buy) | +119,000 | 119,000 | ||
| 2026-02-03 | Farokhzad Omid CEO AND CHAIR | Grant or award | +697,162 | 3,373,449 | ||
| 2026-02-03 | Farokhzad Omid CEO AND CHAIR | Grant or award · Employee Stock Option (right to buy) | +512,000 | 512,000 | ||
| 2025-12-09 | Farokhzad Omid CEO AND CHAIR | Conversion | +1,438,057 | 2,676,287 | ||
| 2025-12-09 | Farokhzad Omid CEO AND CHAIR | Conversion | +2,117,138 | 2,117,138 | ||
| 2025-12-09 | Farokhzad Omid CEO AND CHAIR | Conversion · Class B Common Stock | −1,438,057 | 0 | ||
| 2025-12-09 | Farokhzad Omid CEO AND CHAIR | Conversion · Class B Common Stock | −2,117,138 | 0 | ||
| 2025-12-09 | MCGUIRE TERRANCE Director | Conversion | +4,088 | 215,070 | ||
| 2025-12-09 | MCGUIRE TERRANCE Director | Conversion · Class B Common Stock | −4,088 | 0 | ||
| 2025-11-19 | Horn David R. PRESIDENT & CFO | Sale | −6,797 | $1.97 | $13K | 436,802 |
| 2025-11-19 | Farokhzad Omid CEO AND CHAIR | Sale | −33,838 | $1.97 | $67K | 1,238,230 |
| 2025-09-02 | Ro Isaac Director | Grant or award | +41,000 | 41,000 | ||
| 2025-09-02 | Ro Isaac Director | Grant or award · Stock Option (right to buy) | +61,000 | 61,000 | ||
| 2025-08-20 | Horn David R. PRESIDENT & CFO | Sale | −6,827 | $2.04 | $14K | 436,802 |
| 2025-08-20 | Farokhzad Omid CEO AND CHAIR | Sale | −33,992 | $2.04 | $69K | 1,272,068 |
| 2025-07-07 | Roelofs Nicolas H PHD Director | Grant or award | +17,083 | 74,996 | ||
| 2025-07-07 | Roelofs Nicolas H PHD Director | Grant or award · Stock Option (right to buy) | +25,416 | 25,416 | ||
| 2025-07-07 | Nishar Dipchand Director | Grant or award | +20,500 | 69,704 |
Page 2 of 10 · 196 trades